Treatment of type 2 diabetic rats induced by intraperitoneal (i.p.)injection (58) of streptozotocin (STZ) with CM (35 ml/rat/day), reduced the level of transforming growth factor beta 1 (TGF-β1) which indicate anti-inflammatory activities. The gene discussed is TGFB1; the disease is type 2 diabetes mellitus.